Investigational Site Number : 7240007

Oviedo, Principality of Asturias 33011

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Studies at this site

• Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC — Stopped early
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed